Showing 1 - 17 results of 17 for search 'Daniele Lavacchi', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience by Daniele Lavacchi, Giandomenico Roviello, Elisa Giommoni, Lorenzo Dreoni, Silvia Derio, Marco Brugia, Amedeo Amedei, Serena Pillozzi, Lorenzo Antonuzzo
Published 2021-07-01
Article -
5
Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective by Daniele Lavacchi, Elisa Pellegrini, Valeria Emma Palmieri, Laura Doni, Marinella Micol Mela, Fabrizio Di Maida, Amedeo Amedei, Serena Pillozzi, Marco Carini, Lorenzo Antonuzzo
Published 2020-06-01
Article -
6
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer by Daniele Lavacchi, Giandomenico Roviello, Alessia Guidolin, Silvia Romano, Jacopo Venturini, Enrico Caliman, Agnese Vannini, Elisa Giommoni, Elisa Pellegrini, Marco Brugia, Serena Pillozzi, Lorenzo Antonuzzo
Published 2023-03-01
Article -
7
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy by Jasminka Hasic Telalovic, Serena Pillozzi, Rachele Fabbri, Alice Laffi, Daniele Lavacchi, Virginia Rossi, Lorenzo Dreoni, Francesca Spada, Nicola Fazio, Amedeo Amedei, Ernesto Iadanza, Lorenzo Antonuzzo
Published 2021-04-01
Article -
8
Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis by Agnese Paderi, Elisabetta Gambale, Cristina Botteri, Roberta Giorgione, Daniele Lavacchi, Marco Brugia, Francesca Mazzoni, Elisa Giommoni, Susanna Bormioli, Amedeo Amedei, Serena Pillozzi, Marco Matucci Cerinic, Lorenzo Antonuzzo
Published 2021-09-01
Article -
9
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing by Daniele Lavacchi, Sara Fancelli, Eleonora Buttitta, Gianmarco Vannini, Alessia Guidolin, Costanza Winchler, Enrico Caliman, Agnese Vannini, Elisa Giommoni, Marco Brugia, Fabio Cianchi, Serena Pillozzi, Giandomenico Roviello, Lorenzo Antonuzzo
Published 2023-03-01
Article -
10
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients by Daniele Lavacchi, Simone Polvani, Antonio Taddei, Antonio Taddei, Federico Scolari, Luca Messerini, Enrico Caliman, Luca Moraldi, Alessia Guidolin, Gian Luca Grazi, Andrea Galli, Serena Pillozzi, Lorenzo Antonuzzo, Lorenzo Antonuzzo
Published 2023-12-01
Article -
11
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients by Daniele Lavacchi, Stefania Gelmini, Adele Calabri, Gemma Rossi, Lisa Simi, Enrico Caliman, Irene Mancini, Francesca Salvianti, Giulia Petroni, Alessia Guidolin, Federico Scolari, Luca Messerini, Serena Pillozzi, Pamela Pinzani, Lorenzo Antonuzzo
Published 2023-11-01
Article -
12
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy by Enrico Caliman, Sara Fancelli, Carlotta Ottanelli, Francesca Mazzoni, Luca Paglialunga, Daniele Lavacchi, Marta Rita Gatta Michelet, Elisa Giommoni, Brunella Napolitano, Federico Scolari, Luca Voltolini, Camilla Eva Comin, Serena Pillozzi, Lorenzo Antonuzzo
Published 2022-01-01
Article -
13
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer by Daniele Lavacchi, Sara Fancelli, Sara Fancelli, Giandomenico Roviello, Francesca Castiglione, Enrico Caliman, Enrico Caliman, Gemma Rossi, Jacopo Venturini, Elisa Pellegrini, Marco Brugia, Agnese Vannini, Caterina Bartoli, Fabio Cianchi, Serena Pillozzi, Serena Pillozzi, Lorenzo Antonuzzo, Lorenzo Antonuzzo, Lorenzo Antonuzzo
Published 2022-11-01
Article -
14
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas by Jessica Iorio, Lorenzo Antonuzzo, Emanuela Scarpi, Massimo D’Amico, Claudia Duranti, Luca Messerini, Clotilde Sparano, Damiano Caputo, Daniele Lavacchi, Domenico Borzomati, Alice Antonelli, Lorenzo Nibid, Giuseppe Perrone, Alessandro Coppola, Roberto Coppola, Francesco di Costanzo, Elena Lastraioli, Annarosa Arcangeli
Published 2022-09-01
Article -
15
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience by Margherita Rimini, Valentina Burgio, Lorenzo Antonuzzo, Lorenza Rimassa, Ester Oneda, Caterina Soldà, Pasqua Cito, Guglielmo Nasti, Daniele Lavacchi, Valentina Zanuso, Mario Domenico Rizzato, Alberto Zaniboni, Alessandro Ottaiano, Mara Persano, Noemi Cornara, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini
Published 2023-07-01
Article -
16
Results of the observational prospective RealFLOT study by Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino, Lorenzo Fornaro, Francesco Iachetta, Carmelo Pozzo, Maria Antonietta Satolli, Andrea Spallanzani, Marco Puzzoni, Silvia Stragliotto, Michele Sisani, Vincenzo Formica, Filippo Giovanardi, Antonia Strippoli, Michele Prisciandaro, Samantha Di Donato, Luca Pompella, Irene Pecora, Alessandra Romagnani, Sara Fancelli, Marco Brugia, Serena Pillozzi, Ferdinando De Vita, Lorenzo Antonuzzo
Published 2021-10-01
Article -
17
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real... by Sara Fancelli, Sara Fancelli, Enrico Caliman, Enrico Caliman, Francesca Mazzoni, Luca Paglialunga, Marta Rita Gatta Michelet, Daniele Lavacchi, Rossana Berardi, Giulia Mentrasti, Giulio Metro, Ilaria Birocchi, Angelo Delmonte, Ilaria Priano, Camilla Eva Comin, Camilla Eva Comin, Francesca Castiglione, Caterina Bartoli, Luca Voltolini, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuzzo, Lorenzo Antonuzzo, Lorenzo Antonuzzo
Published 2022-11-01
Article